» Articles » PMID: 23094225

Expression of Intercellular Adhesion Molecule-1 and E-selectin in Gastric Cancer and Their Clinical Significance

Overview
Date 2012 Oct 25
PMID 23094225
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Among cell adhesion molecules, serum levels of intercellular adhesion molecule-1 and E-selectin are known to be correlated with the metastatic potential of gastric cancer. In the present study, the authors investigated the expression of intercellular adhesion molecule-1 and E-selectin in gastric cancer tissues and cultured gastric cancer cells, and examined their clinical value in gastric cancer.

Materials And Methods: The protein was extracted from gastric cancer tissues and cultured gastric cancer cells (MKN-28 and Kato-III) and the expression of intercellular adhesion molecule-1 and E-selectin was examined by western blotting. The clinical significance of intercellular adhesion molecule-1 and E-selectin was explored, using immunohistochemical staining of specimens from 157 gastric cancer patients.

Results: In western blot analysis, the expressions of intercellular adhesion molecule-1 in gastric cancer tissues and cultured gastric cancer cells were increased, however, E-selectin in gastric cancer tissues and cells were not increased. Among 157 gastric cancer patients, 79 patients (50%) were intercellular adhesion molecule-1 positive and had larger tumor size, an increased depth of tumor invasion, lymph node metastasis and perineural invasion. The intercellular adhesion molecule-1 positive group showed a higher incidence of tumor recurrence (40.5%), and a poorer 3-year survival than the negative group (54.9 vs. 85.9%, respectively).

Conclusions: Intercellular adhesion molecule-1 is overexpressed in gastric cancer tissues and cultured gastric cancer cells, whereas E-selectin is not overexpressed. Increased expression of intercellular adhesion molecule-1 in gastric cancer could be related to the aggressive nature of the tumor, and has a poor prognostic effect on gastric cancer.

Citing Articles

Novel immunotherapeutic approaches in gastric cancer.

Yang M, Lin W, Huang J, Mannucci A, Luo H Precis Clin Med. 2024; 7(4):pbae020.

PMID: 39397869 PMC: 11467695. DOI: 10.1093/pcmedi/pbae020.


Abnormal DNA methylation analysis of leucine-rich glioma-inactivated 1 antibody encephalitis reveals novel methylation-driven genes related to prognostic and clinical features.

Qiao S, Sun Q, Li H, Yin J, Wang A, Zhang S Clin Epigenetics. 2023; 15(1):139.

PMID: 37644514 PMC: 10463459. DOI: 10.1186/s13148-023-01550-5.


Multi-Targeting Anticancer Activity of a New 4-Thiazolidinone Derivative with Anti-HER2 Antibodies in Human AGS Gastric Cancer Cells.

Gornowicz A, Lesyk R, Czarnomysy R, Holota S, Shepeta Y, Poplawska B Int J Mol Sci. 2023; 24(7).

PMID: 37047765 PMC: 10095353. DOI: 10.3390/ijms24076791.


Roles of intercellular cell adhesion molecule-1 (ICAM-1) in colorectal cancer: expression, functions, prognosis, tumorigenesis, polymorphisms and therapeutic implications.

Qiu Z, Wang Y, Zhang Z, Qin R, Peng Y, Tang W Front Oncol. 2022; 12:1052672.

PMID: 36505809 PMC: 9728583. DOI: 10.3389/fonc.2022.1052672.


From Anti-HER-2 to Anti-HER-2-CAR-T Cells: An Evolutionary Immunotherapy Approach for Gastric Cancer.

Sun J, Li X, Chen P, Gao Y J Inflamm Res. 2022; 15:4061-4085.

PMID: 35873388 PMC: 9304417. DOI: 10.2147/JIR.S368138.


References
1.
Fidler I . Critical determinants of metastasis. Semin Cancer Biol. 2002; 12(2):89-96. DOI: 10.1006/scbi.2001.0416. View

2.
Fujihara T, Yashiro M, Inoue T, Sawada T, Kato Y, Ohira M . Decrease in ICAM-1 expression on gastric cancer cells is correlated with lymph node metastasis. Gastric Cancer. 2002; 2(4):221-225. DOI: 10.1007/s101200050067. View

3.
Sanchez-Rovira P, Jimenez E, Carracedo J, Barneto I, Ramirez R, Aranda E . Serum levels of intercellular adhesion molecule 1 (ICAM-1) in patients with colorectal cancer: inhibitory effect on cytotoxicity. Eur J Cancer. 1998; 34(3):394-8. DOI: 10.1016/s0959-8049(97)10033-8. View

4.
Yashiro M, Sunami T, Hirakawa K . CD54 expression is predictive for lymphatic spread in human gastric carcinoma. Dig Dis Sci. 2006; 50(12):2224-30. DOI: 10.1007/s10620-005-3039-1. View

5.
Maruo Y, Gochi A, Kaihara A, Shimamura H, Yamada T, Tanaka N . ICAM-1 expression and the soluble ICAM-1 level for evaluating the metastatic potential of gastric cancer. Int J Cancer. 2002; 100(4):486-90. DOI: 10.1002/ijc.10514. View